The Global Veterinary Molecular Diagnostics Market was valued at US$ 1.31 billion in 2025 and is expected to reach US$ 2.61 billion by 2034, registering a CAGR of 7.96% during 2026–2034. Increasing awareness of animal health, rising prevalence of infectious diseases, growing pet ownership, and advancements in molecular testing technologies are supporting market expansion. Veterinary molecular diagnostics helps identify pathogens and genetic abnormalities with greater accuracy, enabling veterinarians and livestock producers to make informed healthcare decisions.
The Veterinary Molecular Diagnostics Market Opportunities are expanding as animal healthcare providers increasingly adopt advanced diagnostic methods for early disease detection, preventive treatment, and disease surveillance. Technologies such as polymerase chain reaction (PCR), real-time PCR, DNA sequencing, and microarrays are improving diagnostic accuracy and turnaround times. Growing investments in veterinary healthcare infrastructure and the integration of molecular testing into routine clinical practices are also creating opportunities for diagnostic manufacturers and service providers.
Veterinary Molecular Diagnostics Market Overview
Veterinary molecular diagnostics involves analyzing genetic material, including DNA and RNA, to identify infectious agents, inherited conditions, and other disease-related markers in animals. These technologies support the diagnosis of viral, bacterial, fungal, and parasitic infections in companion animals and livestock. Molecular testing can also help identify genetic traits, support breeding programs, and monitor diseases that may spread between animals and humans.
The growing importance of animal health has increased demand for reliable diagnostic solutions. Companion animal owners are becoming more willing to invest in advanced veterinary services, while livestock producers are prioritizing herd health, productivity, and disease prevention. Molecular diagnostics enables early identification of infections, helping veterinarians initiate appropriate treatment and reduce the risk of disease transmission.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040023
Key Drivers Supporting Market Growth
Increasing Prevalence of Animal Infectious Diseases: The rising occurrence of infectious diseases among companion animals and livestock is a major factor driving demand for veterinary molecular diagnostics. Diseases such as avian influenza, African swine fever, and other bacterial and viral infections require accurate detection and continuous monitoring. Molecular diagnostic methods help identify pathogens and support timely disease-control measures. The growing focus on zoonotic disease surveillance is further encouraging the adoption of advanced testing technologies.
Growing Pet Ownership and Spending on Animal Healthcare: Increasing pet adoption and the humanization of companion animals are contributing to higher expenditure on veterinary services. Pet owners are increasingly seeking preventive healthcare, routine screening, and advanced diagnostic procedures. Veterinary clinics and hospitals are adopting molecular testing to improve disease identification and treatment planning. This trend is creating opportunities for companies offering diagnostic kits, reagents, instruments, and laboratory services.
Advancements in Diagnostic Technologies: Technological developments in PCR, next-generation sequencing, and automated testing platforms are improving the speed and precision of veterinary diagnostics. Multiplex PCR panels can detect multiple pathogens in a single test, while sequencing technologies provide detailed information about pathogen characteristics and genetic variations. Point-of-care molecular testing is also gaining attention because it can reduce the time required to obtain diagnostic results and support faster clinical decisions.
Emerging Trends in the Veterinary Molecular Diagnostics Market
The adoption of automated and high-throughput diagnostic systems is an important trend shaping the industry. Veterinary diagnostic laboratories are investing in advanced instruments that can process larger sample volumes while maintaining testing consistency. Automation also helps reduce manual intervention and improve laboratory efficiency.
Another emerging trend is the growing use of genetic testing in animal breeding and healthcare. Molecular methods can help identify inherited conditions, genetic traits, and variations associated with animal health and productivity. Livestock breeders are increasingly using genomic information to support selective breeding and improve herd characteristics.
Leading Companies in the Veterinary Molecular Diagnostics Market
Major companies operating in the Veterinary Molecular Diagnostics Market include:
- IDEXX Laboratories, Inc.
- Zoetis Inc.
- Thermo Fisher Scientific Inc.
- Virbac
- QIAGEN N.V.
- Biogal Galed Labs
- Abaxis Inc. (now part of Zoetis)
- Randox Laboratories
- Neogen Corporation
These companies focus on expanding diagnostic product portfolios, improving testing technologies, and strengthening their presence across veterinary healthcare markets. Investments in research and development, product innovation, strategic partnerships, and distribution networks are important competitive strategies. The growing demand for accurate and efficient animal disease testing is encouraging market participants to develop solutions for both companion animal and livestock applications.
Regional Opportunities and Industry Expansion
North America represents an important market for veterinary molecular diagnostics because of its established veterinary healthcare infrastructure, high pet ownership, and adoption of advanced diagnostic technologies. The presence of major animal health companies and diagnostic laboratories also supports product development and commercialization.
Europe offers growth opportunities through increasing awareness of animal welfare, disease surveillance, and preventive veterinary care. Meanwhile, Asia Pacific is creating opportunities as livestock production expands, companion animal ownership increases, and veterinary healthcare infrastructure improves. Investments in diagnostic laboratories and growing awareness of zoonotic diseases are expected to support demand across emerging economies.
Future Outlook
The Veterinary Molecular Diagnostics Market is expected to experience continued development as veterinary healthcare increasingly emphasizes early diagnosis, preventive treatment, and precision animal health. Advances in PCR, sequencing, automation, and point-of-care testing are likely to improve accessibility and diagnostic efficiency. Growing collaboration among veterinary laboratories, research institutions, and animal health companies will also support innovation. As awareness of animal diseases and zoonotic risks increases, molecular diagnostics is expected to become an increasingly important part of veterinary healthcare and livestock management.
Related Reports:
Gene Therapy CDMO Market Growth, Share, and Forecast (2026-2034)
Cell Therapy CDMO Market Size, Share and Forecast by 2031
About Us
The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.
Contact US
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
E-mail : sales@theinsightpartners.com